Advertisement

Journal of Behavioral Medicine

, Volume 37, Issue 1, pp 94–101 | Cite as

Effects of estrogen and opioid blockade on blood pressure reactivity to stress in postmenopausal women

  • Allyssa J. Allen
  • James A. McCubbinEmail author
  • James P. Loveless
  • Suzanne G. Helfer
Original Paper

Abstract

Estrogen may influence coronary heart disease risk in women through the effects of endogenous opioids on autonomic control of blood pressure. In a randomized, placebo-controlled trial, we examined the combined effects of estrogen and the opioid antagonist, naltrexone, on blood pressure responses to psychological stress in 42 postmenopausal women. After 3 months of estrogen or estrogen plus progestin (hormone replacement therapy; n = 27) or placebo replacement, participants completed a mental arithmetic task after administration of .7 mg/kg oral naltrexone or placebo. Systolic blood pressure (SBP), diastolic blood pressure, mean arterial pressure and heart rate (HR) were measured at rest and during the arithmetic stressor. Stress produced significant increases in circulatory measures regardless of estrogen condition or opioid blockade (p’s < .001). Interestingly, there was an estrogen by naltrexone interaction on SBP reactivity scores [F(1,38) = 4.36, p < .05], where women on estrogen with intact opioid receptors showed the largest SBP responses to stress, compared with all other conditions. This is consistent with some studies of premenopausal women, suggesting that estrogens may alter opioid function during stress. The interaction between estrogen and endogenous opioids may explain sex differences in opioid effects on stress reactivity in younger premenopausal women.

Keywords

Hormone replacement therapy Endogenous opioids Naltrexone Women’s health Cardiovascular risk Coronary heart disease 

References

  1. Akil, H., Watson, S., Young, E., Lewis, M., Khachaturian, H., & Walker, J. (1984). Endogenous opioids: Biology and function. Annual Review of Neuroscience, 7, 223–255.PubMedCrossRefGoogle Scholar
  2. Al’Absi, M., Hatsukami, D., Davis, G., & Wittmers, L. (2004). Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug and Alcohol Dependence, 73, 267–278.PubMedCrossRefGoogle Scholar
  3. Allen, M., Stoney, C., Owens, J., & Matthews, K. (1993). Hemodynamic adjustments to laboratory stress: The influence of gender and personality. Psychosomatic Medicine, 55, 505.PubMedGoogle Scholar
  4. American Heart Association. (2010). Heart disease and stroke statistics2010 update. Retrieved from http://www.americanheart.org/downloadable/heart/1265665152970DS-3241%20HeartStrokeUpdate_2010.pdf.
  5. Barrett-Connor, E., & Grady, D. (1998). Hormone replacement therapy, heart disease, and other considerations. Annual Review of Public Health, 19, 55–72.PubMedCrossRefGoogle Scholar
  6. Behrens, C., Aurich, J., Klug, E., Naumann, H., & Hoppen, H. (1993). Inhibition of gonadotrophin release in mares during the luteal phase of the oestrous cycle by endogenous opioids. Reproduction, 98, 509.CrossRefGoogle Scholar
  7. Brawer, J., Beaudet, A., Desjardins, G., & Schipper, H. (1993). Pathologic effect of estradiol on the hypothalamus. Biology of Reproduction, 49, 647–652.Google Scholar
  8. Burleson, M., Malarkey, W., Cacioppo, J., Poehlmann, K., Kiecolt-Glaser, J., Berntson, G., et al. (1998). Postmenopausal hormone replacement: Effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosomatic Medicine, 60, 17–25.PubMedGoogle Scholar
  9. Butler, R., & Finn, D. (2009). Stress-induced analgesia. Progress in Neurobiology, 88, 184–202.PubMedCrossRefGoogle Scholar
  10. Chida, Y., & Steptoe, A. (2010). Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status. A meta-analysis of prospective evidence. Hypertension, 55, 1026–1032.PubMedCrossRefGoogle Scholar
  11. Craft, R., Mogil, J., & Maria Aloisi, A. (2004). Sex differences in pain and analgesia: The role of gonadal hormones. European Journal of Pain, 8, 397–411.PubMedCrossRefGoogle Scholar
  12. Dedovic, K., Wadiwalla, M., Engert, V., & Pruessner, J. (2009). The role of sex and gender socialization in stress reactivity. Developmental Psychology, 45, 45–55.PubMedCrossRefGoogle Scholar
  13. Drolet, G., Dumont, E. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J. (2001). Role of endogenous opioid system in the regulation of the stress response. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 729–741.PubMedCrossRefGoogle Scholar
  14. Farag, N., Vincent, A., & McKey, B. (2006). Sex differences in the hemodynamic responses to mental stress: Effect of caffeine consumption. Psychophysiology, 43, 337–343.PubMedCentralPubMedCrossRefGoogle Scholar
  15. Faul, F., Erdfelder, E., Lange, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175–191.PubMedCrossRefGoogle Scholar
  16. Fillingim, R., & Ness, T. (2000). Sex-related hormonal influences on pain and analgesic responses. Neuroscience and Biobehavioral Reviews, 24, 485–501.PubMedCrossRefGoogle Scholar
  17. Fraioli, F. (1984). Lack of endogenous opioid inhibitory tone on LH secretion in early puberty. Clinical Endocrinology, 20, 299–305.PubMedCrossRefGoogle Scholar
  18. Frankenhauser, M. (1983). The sympathetic-adrenal and pituitary-adrenal response to challenge: Comparison between the sexes. In T. M. Dembroksi, T. H. Schmidt, & G. Blumchen (Eds.), Biobehavioral bases of coronary heart disease (pp. 91–103). New York, NY: Transaction.Google Scholar
  19. Holaday, J. (1983). Cardiovascular effects of endogenous opiate systems. Annual Review of Pharmacology and Toxicology, 23, 541.PubMedCrossRefGoogle Scholar
  20. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association, 280, 605.PubMedCrossRefGoogle Scholar
  21. Iyengar, S., Kim, H., & Wood, P. (1987). [mu]-,[delta]-,[kappa]-and [epsilon]-Opioid receptor modulation of the hypothalamic–pituitary–adrenocortical (HPA) axis: Subchronic tolerance studies of endogenous opioid peptides. Brain Research, 435, 220–226.PubMedCrossRefGoogle Scholar
  22. Komesaroff, P., Esler, M., & Sudhir, K. (1999). Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. Journal of Clinical Endocrinology and Metabolism, 84, 606.PubMedGoogle Scholar
  23. Kudielka, B., & Kirschbaum, C. (2005). Sex differences in HPA axis responses to stress: A review. Biological Psychology, 69, 113.PubMedCrossRefGoogle Scholar
  24. Lash, S., Gillespie, B., Eisler, R., & Southard, D. (1991). Sex differences in cardiovascular reactivity: Effects of the gender relevance of the stressor. Health Psychology, 10, 392–398.PubMedCrossRefGoogle Scholar
  25. Lindheim, S., Legro, R., Bernstein, L., Stanczyk, F., Vijod, M., Presser, S., et al. (1992). Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. American Journal of Obstetrics and Gynecology, 167, 1831–1836.PubMedCrossRefGoogle Scholar
  26. Litschauer, B., Schaller, G., & Wolzt, M. (2005). Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women. American Journal of Physiology: Heart and Circulatory Physiology, 289, H2120.PubMedGoogle Scholar
  27. Manson, J. A. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., et al. (2003). Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine, 349, 523–534.PubMedCrossRefGoogle Scholar
  28. McCubbin, J. (1993). Stress and endogenous opioids: Behavioral and circulatory interactions. Biological Psychology, 35, 91–122.PubMedCrossRefGoogle Scholar
  29. McCubbin, J., Helfer, S., Switzer, F., & Price, T. (2002). Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease. American Heart Journal, 143, 711–717.PubMedCrossRefGoogle Scholar
  30. McCubbin, J. A., Kaplan, J. R., Manuck, S. B., & Adams, M. R. (1993). Opioidergic inhibition of circulatory and endocrine stress responses in cynomolgus monkeys: A preliminary study. Psychosomatic Medicine, 55, 23–28.PubMedGoogle Scholar
  31. McCubbin, J. A., Surwit, R. S., Williams, R. B., Nemeroff, C. B., & McNeilly, M. (1989). Altered pituitary hormone response to naloxone in hypertension development. Hypertension, 14, 636–644.PubMedCrossRefGoogle Scholar
  32. McCubbin, J., Wilson, J., Bruehl, S., Ibarra, P., Carlson, C., Norton, J., et al. (1996). Relaxation training and opioid inhibition of blood pressure response to stress. Journal of Consulting and Clinical Psychology, 64, 593–601.PubMedCrossRefGoogle Scholar
  33. Mendelsohn, M., & Karas, R. (1999). The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340, 1801.PubMedCrossRefGoogle Scholar
  34. Morris, M., Salmon, P., Steinberg, H., Sykes, E., Bouloux, P., Newbould, E., et al. (1990). Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology, 15, 185–192.PubMedCrossRefGoogle Scholar
  35. Owens, J., Stoney, C., & Matthews, K. (1993). Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation, 88, 2794–2802.PubMedCrossRefGoogle Scholar
  36. Petraglia, F., Porro, C., Facchinetti, F., Cicoli, C., Bertellini, E., Volpe, A., et al. (1986). Opioid control of LH secretion in humans: Menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sciences, 38, 2103–2110.PubMedCrossRefGoogle Scholar
  37. Rossouw, J., Prentice, R., Manson, J., Wu, L., Barad, D., Barnabei, V., et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Journal of the American Medical Association, 297, 1465–1477.PubMedGoogle Scholar
  38. Saab, P., Matthews, K., Stoney, C., & McDonald, R. (1989). Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology, 26, 270–280.PubMedCrossRefGoogle Scholar
  39. Stoney, C., Davis, M., & Matthews, K. (1987). Sex differences in physiological responses to stress and in coronary heart disease: A causal link? Psychophysiology, 24, 127–131.PubMedCrossRefGoogle Scholar
  40. Stroud, L., Niaura, R., & Stoney, C. (2001). Sex differences in cardiovascular reactivity to physical appearance and performance challenges. International Journal of Behavioral Medicine, 8, 240–250.CrossRefGoogle Scholar
  41. Taylor, S., Klein, L., Lewis, B., Gruenewald, T., Gurung, R., & Updegraff, J. (2000). Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight. Psychological Review, 107, 411–429.PubMedCrossRefGoogle Scholar
  42. Uchino, B., Uno, D., Holt-Lunstad, J., & Flinders, J. (1999). Age-related differences in cardiovascular reactivity during acute psychological stress in men and women. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 54, P339.CrossRefGoogle Scholar
  43. Veldhuis, J., Kulin, H., Warner, A., & Santer, S. (1982). Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. Journal of Clinical Endocrinology and Metabolism, 55, 649–653.PubMedCrossRefGoogle Scholar
  44. Veldhuis, J., Rogol, A., Samojlik, E., & Ertel, N. (1984). Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. Journal of Clinical Investigation, 74, 47–55.PubMedCentralPubMedCrossRefGoogle Scholar
  45. Vitale, C., Mendelsohn, M., & Rosano, G. (2009). Gender differences in the cardiovascular effect of sex hormones. Nature Reviews Cardiology, 6, 532–542.PubMedCrossRefGoogle Scholar
  46. Weiland, N., & Wise, P. (1990). Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology, 126, 804.PubMedCrossRefGoogle Scholar
  47. Whited, M., & Larkin, K. (2009). Sex differences in cardiovascular reactivity. Journal of Psychophysiology, 23, 77–84.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Allyssa J. Allen
    • 1
  • James A. McCubbin
    • 2
    Email author
  • James P. Loveless
    • 2
  • Suzanne G. Helfer
    • 3
  1. 1.University of Maryland, Baltimore CountyBaltimoreUSA
  2. 2.Department of PsychologyClemson UniversityClemsonUSA
  3. 3.Adrian CollegeAdrianUSA

Personalised recommendations